TC Medical(SH:600763) Sou Hu Cai Jing·2025-08-29 13:42Core Viewpoint - Tongce Medical (600763) shows a mixed performance in terms of stock price and fund flow, with a slight increase in stock price but significant net outflow of main funds on August 29, 2025 [1][2]. Fund Flow Summary - On August 29, 2025, the stock closed at 47.14 yuan, up 1.77%, with a turnover rate of 4.04% and a trading volume of 180,600 lots, amounting to a total transaction value of 854 million yuan [1]. - The fund flow data indicates a net outflow of main funds amounting to 35.41 million yuan, accounting for 4.15% of the total transaction value, while retail investors saw a net inflow of 18.27 million yuan, representing 2.14% of the total [1][2]. Recent Fund Flow Overview - The recent five-day fund flow shows a trend of net outflows from main funds, with the most significant outflow occurring on August 27, 2025, at 95.11 million yuan, while retail investors consistently showed net inflows [2]. Company Performance Metrics - As of the latest report, Tongce Medical has a total market value of 21.085 billion yuan, with a net asset value of 4.467 billion yuan and a net profit of 321 million yuan [3]. - The company reported a year-on-year increase in main revenue of 2.68% to 1.448 billion yuan and a net profit increase of 3.67% to 321 million yuan for the first half of 2025 [3]. - The second quarter of 2025 showed a slight increase in main revenue to 704 million yuan, with a net profit of 137 million yuan, reflecting a year-on-year increase of 0.44% [3]. Industry Comparison - Tongce Medical's price-to-earnings ratio (P/E) stands at 32.83, significantly lower than the industry average of 84.92, indicating a favorable valuation compared to peers [3]. - The company's gross margin is 40.75%, higher than the industry average of 35.7%, and its net margin of 26.26% is substantially above the industry average of 3.53% [3]. Analyst Ratings - Over the past 90 days, six institutions have rated the stock, with four buy ratings and two hold ratings, and the average target price set at 50.19 yuan [4].